Trial Design Solutions

  1. The #1 Rated Leader In DCT Now Offers The Vaccine Pathway 6/17/2022

    Explore an expertly crafted package of programs, products, and expertise addressing the unique challenges of vaccine research.

  2. Think Bold. Think Scientific. Think Veristat. 9/8/2022

    Veristat harnesses knowledge, expertise, and scale to provide superior solutions and progressive approaches to mitigate risks and achieve meaningful outcomes for biopharmaceutical and medical technology companies, and their patients.

  3. Only Elligo Mitigates Research Risk 4/18/2023

    Uncertainty is inherent in clinical research. Uncover new strategies and solutions to alleviate risk so clinical teams can confidently and quickly bring products to market.

  4. Why Leading Cancer Research Centers Trust OpenClinica For Oncology Trials 7/16/2024

    See eight key reasons why leading cancer research centers rely on OpenClinica to navigate the intricacies of oncology trials and advance the field of cancer research.

  5. Introducing Citeline PatientMatch: Precision Patient Recruitment 4/26/2024

    The window for identifying the right patients to enroll in clinical trials is shrinking. With Citeline PatientMatch, sponsors can pinpoint eligible patients before a treatment plan is finalized.

  6. IRB Review Services For Phase I Research 12/22/2021

    With experience overseeing thousands of Phase I studies in the US and Canada, Advarra’s institutional review board (IRB) understands the unique requirements of Phase I study design and conduct. Our dedicated team and processes are built to support your Phase I research needs.

  7. Rare Disease Center Of Excellence Overcomes Unique Obstacles 7/14/2022

    Biorasi’s Beeline platform provides clinical teams with unique, real-time transparency for quick responses to rare and urgent disease trial challenges.

  8. Optimizing Clinical Trial Planning 10/1/2024

    From pinpointing patient populations to projecting enrollment and site capacity, TA Scan transforms clinical trial planning into a data-driven, results-oriented process

  9. NextGen Participant Engagement Platform 11/16/2023

    Uncover how the GreenSpace platform can address delays in trial timelines by overcoming insufficient recruitment and retention efforts.

  10. Rave RTSM: Direct-To-Patient 10/3/2022

    As the healthcare industry continues to deepen its focus on virtual trials and patient-centricity, the popularity of Direct-to-Patient (DtP) services in the clinical trial setting has grown significantly. Rave RTSM DtP (Randomization and Trial Supply Management Direct to Patient) brings investigational medicinal products (IMP) directly to a patient’s home, bypassing the need for the patient to travel directly to a site.